comprehensive -WSS

comprehensive

author：explore 2025-09-06 04:50:48 - browse：68

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： What will Novo Nordisk's VC do with its influx of cash?

Wikipedia

WSS

Gene editing the human germline: What are the risks?

Lawsuit highlights wrinkle for disputes over surprise medical bills

Methadone treatment changes are coming. Do they go far enough?

Gene editing the human germline: What are the risks?

Health AI adoption puts security, privacy startups on investors' radar

Intermittent fasting comes with a heart risk? Not so fast

focus

comprehensive

entertainment

Supreme Court strikes down use of affirmative action

Health AI adoption puts security, privacy startups on investors' radar

Wildfire smoke exposes gaps in outdoor worker protections

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Sports medicine is finally prioritizing gender equality

U.K. researchers warn about biases in medical devices, algorithms

Medical leaders decry Supreme Court decision on affirmative action

Physicians and social media: If you see something, say something?

Bright Health sells Medicare Advantage business to Molina

Some top drug companies are starting to take action on climate

explore

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Will an HIV vaccine ever be a reality?

Neuroscience’s long legacy of racism

Leading voice in opioid treatment defends methadone clinic system

CRISPR base editing slashes cholesterol levels in monkeys

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Wikipedia

entertainment

Wikipedia

knowledge